CClinicalTrials.gg
TerminatedNCT02197663Updated Oct 22, 2015

Clinical Evaluation of Acupuncture on the Complications of Cerebral Vascular Accident

A Phase 1 interventional study of acupuncture(44mm in length and 32-gauge) in Stroke, sponsored by China Medical University Hospital. Terminated at 1 site in Taiwan. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2015-10-22.

Sponsored by China Medical University Hospital · Phase 1, Interventional, and Treatment

Why this study was terminated
the numbers of drop-out patients are more than we anticipate
Phase
Phase 1
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

The lifestyle of Taiwanese people has been changed over the past decade with the improvement of economic growth, environmental sanitation and the quality of medical care. Now the investigators pay more attention to the increasing risk of people's diseases of civilization than people's malnutrition and poor quality of environmental sanitation. The cerebrovascular accident (CVA) leads to death and bio-psycho-social dysfunction. The medical care of the patient of cerebrovascular accident cause a lot of money and is a burden of our country.

Our study emphasizes that acupuncture change bio-psycho-social aspects of the patient with cerebrovascular accident. The investigators use some scales to assess efficacy of acupuncture, such as Barthel index, National Institute of Health Stroke Scale, Visual Analogue Scale, Instrumental Activities of Daily Living and Hamilton Depression Rating Scale.

Besides, the investigators notice that there are few journals about acupuncture effect of treating depression following cerebral vascular accident. The investigators may underestimate the amount of people having post-stroke depression. So the investigators use Hamilton Depression Rating Scale to Assess the post-stroke depression of cerebral vascular accident patient.

By assessing bio-psycho-social level of CVA patient, the investigators hope this study will offer them more "Holistic Health Care".

Read the detailed description

We want to assess the effect of acupuncture on stroke patients. The study is a double-blind randomized controlled trial. We need 80 patients altogether. The Inclusion Criteria:

(1)first time stroke(ischemic or hemorrhagic stroke) with paresis or plegia

Exclusion Criteria:

(1)transient ischemic attack (2)brain tumor, brain trauma (3)recurrent stroke (4)multiple organs failure, cancer The whole course of the acupuncture contains 24times(about 3 months). The acupoints are fixed and located over head and limbs.

The whole course of the sham acupuncture contains 24times(about 3 months). The acupoints are fixed and 1cm away from meridian and no acupoints over head were chosen.

The investigators use Barthel index, National Institute of Health Stroke Scale, Hamilton Depression Rating Scale, Instrumental activities of daily living scale and Visual Analogue Scale to assess the effect of acupuncture on stroke patients. Four times of assessment are as below: baseline, after 8th treatment, after 16th treatment, after 24th treatment (the last time of treatment). The course of treatment should be completed within 3 months.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • acupuncture
  • stroke
  • Randomized Controlled Trial
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 60 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

China Medical University Hospital is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • first time stroke(ischemic or hemorrhagic stroke) with paresis or plegia

Exclusion criteria

Exclusion Criteria:

  • transient ischemic attack
  • brain tumor, brain trauma
  • recurrent stroke
  • multiple organs failure, cancer
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Acupuncture

    The total course of the acupuncture contains 24times(about 3 months). The acupoints are fixed and located over head and limbs.

    Procedure: acupuncture(44mm in length and 32-gauge)

  • Sham comparator
    sham acupuncture

    The total course of the acupuncture contains 24times(about 3 months). The acupoints are fixed and 1cm away from meridian and no acupoints over head were chosen.

    Procedure: acupuncture(44mm in length and 32-gauge)

Interventions

  • Procedureacupuncture(44mm in length and 32-gauge)

    The whole course of the acupuncture contains 24times(about 3 months). The acupoints are fixed and located over head and limbs. The whole course of the sham acupuncture contains 24times(about 3 months). The acupoints are fixed and 1cm away from meridian and no acupoints over head were chosen.

    Also known as: acupuncture(4.4cm in length and 32-gauge), shame acupuncture(1.27 cm in length and 40-gauge)

06

What researchers measure

Primary outcomes

  1. Change from baseline in Barthel index at 8 weeks

    Time frame: Baseline and 8 weeks

  2. Change from baseline in Barthel Index at 16 weeks

    Time frame: Baseline, 16 weeks

  3. Change from baseline in Barthel Index at 24 weeks

    Time frame: Baseline, 24 weeks

  4. Change from baseline in National Institute of Health Stroke Scale at 8 weeks

    Time frame: Baseline, 8 weeks

  5. Change from baseline in National Institute of Health Stroke Scale at 16 weeks

    Time frame: Baseline, 16 weeks

  6. Change from baseline in National Institute of Health Stroke Scale at 24 weeks

    Time frame: Baseline, 24 weeks

  7. Change from baseline in Instrumental Activities of Daily Living Scale at 8 weeks

    Time frame: Baseline, 8 weeks

  8. Change from baseline in Instrumental Activities of Daily Living Scale at 16 weeks

    Time frame: Baseline, 16 weeks

  9. Change from baseline in Instrumental Activities of Daily Living Scale at 24 weeks

    Time frame: Baseline, 24 weeks

  10. Change from baseline in Hamilton Depression Rating Scale at 8 weeks

    Time frame: Baseline, 8 weeks

  11. Change from baseline in Hamilton Depression Rating Scale at 16 weeks

    Time frame: Baseline,16 weeks

  12. Change from baseline in Hamilton Depression Rating Scale at 24 weeks

    Time frame: Baseline, 24 weeks

Secondary outcomes

  1. Change from baseline in Visual Analogue Scale at 8 weeks

    Time frame: Baseline, 8 weeks

  2. Change from baseline in Visual Analogue Scale at 16 weeks

    Time frame: Baseline,16 weeks

  3. Change from baseline in Visual Analogue Scale at 24 weeks

    Time frame: Baseline, 24 weeks

07

Study locations

1 site
  • Department of Acupuncture, China Medical University Hospital
    Taichung, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 22, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02197663
Lead sponsor
China Medical University Hospital
Responsible party
Sponsor
First posted
Jul 23, 2014
Start date
Apr 2013
Primary completion
Jul 2015
Completion
Jul 2015
Last update
Oct 22, 2015

Study contacts

Yu-Chen Lee, PHD
study director · Department of Acupuncture, China Medical University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion